|
GS193273: GO:0005578 proteinaceous extracellular matrix
|
|
GS204996: GO:0048858 cell projection morphogenesis
|
|
GS136518: phospholipid transfer protein inducibility QTL 1 (Pltiq1, Published QTL Chr 4)
|
|
GS172194: HP:0002970 Genu varum
|
|
GS201949: GO:0044699 single-organism process
|
|
GS135221: aromatase activity QTL 2 (Aaiq2, Published QTL Chr 4)
|
|
GS136955: weight 3 (Wght3, Published QTL Chr 4)
|
|
GS135220: aromatase activity QTL 1 (Aaiq1, Published QTL Chr 4)
|
|
GS209569: GO:0048667 cell morphogenesis involved in neuron differentiation
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS172618: HP:0000655 Vitreoretinal degeneration
|
|
GS175802: HP:0003272 Abnormality of the hip bone
|
|
GS172294: HP:0001510 Growth delay
|
|
GS174586: HP:0005930 Abnormality of the epiphyses
|
|
GS193268: GO:0005575 cellular_component
|
|
GS202940: GO:0006935 chemotaxis
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS199273: GO:0043233 organelle lumen
|
|
GS175411: HP:0100871 Abnormality of the palm
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS135535: caffeine metabolism QTL 2 (Cafq2, Published QTL Chr 4)
|
|
GS175392: HP:0011003 Severe Myopia
|
|
GS202614: GO:0005594 collagen type IX
|
|
GS174906: HP:0000545 Myopia
|
|
GS136608: colon tumor susceptibility 11 (Scc11, Published QTL Chr 4)
|
|
GS172843: HP:0000481 Abnormality of the cornea
|
|
GS136443: peak bone mineral density 3 (Pbmd3, Published QTL Chr 4)
|
|
GS210237: GO:0000902 cell morphogenesis
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS172054: HP:0001507 Growth abnormality
|
|
GS201251: GO:0044424 intracellular part
|
|
GS136559: QTL for body weight independent of sex 1 (Qbis1, Published QTL Chr 4)
|
|
GS172031: HP:0000364 Hearing abnormality
|
|
GS135839: femoral bone trait QTL 2 (Fbtq2, Published QTL Chr 4)
|
|
GS136046: insulin dependent diabetes susceptibility 25 (Idd25, Published QTL Chr 4)
|
|
GS135460: bone mineral density 6 (Bomd6, Published QTL Chr 4)
|
|
GS135509: body weight at 8 weeks QTL 2 (Bw8q2, Published QTL Chr 4)
|
|
GS194555: GO:0031974 membrane-enclosed lumen
|
|
GS176612: HP:0000272 Malar flattening
|
|
GS197017: GO:0032990 cell part morphogenesis
|
|
GS173048: HP:0005557 Abnormality of the zygomatic arch
|
|
GS209361: GO:0030934 anchoring collagen
|
|
GS135245: adiposity 12 (Adip12, Published QTL Chr 4)
|
|
GS196726: GO:0005783 endoplasmic reticulum
|
|
GS135770: ear healing QTL 2 (Earheal2, Published QTL Chr 4)
|
|
GS170933: HP:0001288 Gait disturbance
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS196080: GO:0040011 locomotion
|
|
GS135330: autoimmune renal vasculitis 2 (Arvm2, Published QTL Chr 4)
|
|
GS179537: GO:0031012 extracellular matrix
|
|
GS172916: HP:0003312 Abnormal form of the vertebral bodies
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS171708: HP:0000359 Abnormality of the inner ear
|
|
GS205439: GO:0031175 neuron projection development
|
|
GS136202: lung tumor shape-determining 4 (Ltsd4, Published QTL Chr 4)
|
|
GS184450: GO:0044420 extracellular matrix part
|
|
GS171253: HP:0002817 Abnormality of the upper limb
|
|
GS136667: skin tumor susceptibility 7 (Skts7, Published QTL Chr 4)
|
|
GS174308: HP:0002979 Bowing of the legs
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS203406: GO:0009653 anatomical structure morphogenesis
|
|
GS201254: GO:0044420 extracellular matrix part
|
|
GS136760: soft tissue heal 4 (Stheal4, Published QTL Chr 4)
|
|
GS174909: HP:0000546 Retinal degeneration
|
|
GS135856: femoral bone morphometry 5 (Fembm5, Published QTL Chr 4)
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS209525: GO:0032989 cellular component morphogenesis
|
|
GS172928: HP:0011729 Abnormality of joint mobility
|
|
GS136772: SGC/Knj cross B6 QTL 1 (Sxbq1, Published QTL Chr 4)
|
|
GS208505: GO:0030198 extracellular matrix organization
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS173991: HP:0000505 Visual impairment
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS135350: Alzheimer's disease modifier 2 (Azdm2, Published QTL Chr 4)
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS174836: HP:0001098 Abnormality of the fundus
|
|
GS171647: HP:0011844 Abnormal appendicular skeleton morphology
|
|
GS175979: HP:0009115 Aplasia/Hypoplasia involving the skeleton
|
|
GS136191: light induced retinal degeneration 2 (Lrdg2, Published QTL Chr 4)
|
|
GS174847: HP:0000940 Abnormal diaphysis morphology
|
|
GS198004: GO:0007399 nervous system development
|
|
GS129104: bone mineral density 7 (Bmd7 Published QTL Chr 4)
|
|
GS193991: GO:0048731 system development
|
|
GS136689: skull morphology 6 (Skull6, Published QTL Chr 4)
|
|
GS135803: elevated serum gp70 1 (Elsgp1, Published QTL Chr 4)
|
|
GS199651: GO:0005198 structural molecule activity
|
|
GS184451: GO:0044421 extracellular region part
|
|
GS172433: HP:0002644 Abnormality of pelvic girdle bone morphology
|
|
GS176099: HP:0000926 Platyspondyly
|
|
GS136823: triglyceride QTL 3 (Tgq3, Published QTL Chr 4)
|
|
GS193270: GO:0005576 extracellular region
|
|
GS175529: HP:0000001 All
|
|
GS136173: lens opacity 1 (Lnopy1, Published QTL Chr 4)
|
|
GS175527: HP:0000006 Autosomal dominant inheritance
|
|
GS176480: HP:0009826 Hypoplasia involving bones of the extremities
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS172353: HP:0004329 Abnormality of the posterior segment of the eye
|
|
GS179226: GO:0005593 FACIT collagen
|
|
GS172311: HP:0100691 Abnormality of the curvature of the cornea
|
|
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
|
|
GS135416: beta-carboline-induced seizures 1 (Bis1, Published QTL Chr 4)
|
|
GS174257: HP:0000309 Abnormality of the midface
|
|
GS172695: HP:0002656 Epiphyseal dysplasia
|
|
GS136050: insulin dependent diabetes susceptibility 9 (Idd9, Published QTL Chr 4)
|
|
GS136820: triglyceride level suppressor 1 (Tgls1, Published QTL Chr 4)
|
|
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS192424: GO:0030934 anchoring collagen
|
|
GS123048: Tretinoin interacting genes (MeSH:D014212) in CTD
|
|
GS136788: TallyHo associated mesenteric fat pad weight (Tafat, Published QTL Chr 4)
|
|
GS208012: GO:0044464 cell part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS174081: HP:0004322 Short stature
|
|
GS136148: lithogenic gene 8 (Lith8, Published QTL Chr 4)
|
|
GS176202: HP:0000479 Abnormality of the retina
|
|
GS176394: HP:0004982 Flat, irregular epiphyses
|
|
GS173167: HP:0100491 Abnormality of the joints of the lower limbs
|
|
GS136571: radiation induced acute myeloid leukemia 3 (Raml3, Published QTL Chr 4)
|
|
GS865: Sey_Pax6_Age_Reduced_Linear_Incr
|
|
GS170894: HP:0006487 Bowing of the long bones
|
|
GS136567: retinoic acid induced forelimb autopod reduction 2 (Rafar2, Published QTL Chr 4)
|
|
GS135242: anti-dsDNA antibody production in NZM 1 (Adaz1, Published QTL Chr 4)
|
|
GS195113: GO:0071841 cellular component organization or biogenesis at cellular level
|
|
GS135544: corpus callosum hemisphere surface size 2 (Ccrs2, Published QTL Chr 4)
|
|
GS205144: GO:0048468 cell development
|
|
GS136738: small testis weight 1 (Smtw1, Published QTL Chr 4)
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS174377: HP:0005927 Aplasia/Hypoplasia involving bones of the hand
|
|
GS204425: GO:0048812 neuron projection morphogenesis
|
|
GS172195: HP:0000504 Abnormality of vision
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS177051: HP:0001155 Abnormality of the hand
|
|
GS196002: GO:0048699 generation of neurons
|
|
GS196728: GO:0005788 endoplasmic reticulum lumen
|
|
GS136743: splenomegaly modifier (Spm1, Published QTL Chr 4)
|
|
GS175665: HP:0006504 Abnormality involving the diaphyses of the limbs
|
|
GS199635: GO:0005622 intracellular
|
|
GS208009: GO:0005201 extracellular matrix structural constituent
|
|
GS136060: immunoregulatory 2 (Im2, Published QTL Chr 4)
|
|
GS83998: cocaine and amphetamine-regulated transcript QTL 2 (Crq2, Published QTL, Chr 4)
|
|
GS173378: HP:0002758 Osteoarthritis
|
|
GS195507: GO:0043062 extracellular structure organization
|
|
GS136150: "lupus in MRL and B6 F2 cross, QTL 1" (Lmb1, Published QTL Chr 4)
|
|
GS136036: induction of brown adipocytes 7 (Iba7, Published QTL Chr 4)
|
|
GS173792: HP:0002815 Abnormality of the knees
|
|
GS135879: femur geometry 3 (Fmgty3, Published QTL Chr 4)
|
|
GS129123: cataract severity (Ctrcts Published QTL Chr 4)
|
|
GS136003: hepatocarcinogen resistance 1 (Hpcr1, Published QTL Chr 4)
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS199634: GO:0005623 cell
|
|
GS136705: systemic lupus erythmatosus suppressor 2 (Sles2, Published QTL Chr 4)
|
|
GS135567: cytokine deficiency colitis susceptibility 9 (Cdcs9, Published QTL Chr 4)
|
|
GS201256: GO:0044422 organelle part
|
|
GS171106: HP:0006496 Aplasia/Hypoplasia involving bones of the upper limbs
|
|
GS175773: HP:0010582 Irregular epiphyses
|
|
GS173743: HP:0001999 Abnormal facial shape
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS135893: gastritis type A susceptibility locus 1 (Gasa1, Published QTL Chr 4)
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS136719: susceptibility to lung cancer 21 (Sluc21, Published QTL Chr 4)
|
|
GS181440: GO:0005581 collagen
|
|
GS196302: GO:0031012 extracellular matrix
|
|
GS135899: granulosa cell tumorigenesis 1 (Gct1, Published QTL Chr 4)
|
|
GS135309: anxiety (Anxty, Published QTL Chr 4)
|
|
GS195110: GO:0071842 cellular component organization at cellular level
|
|
GS135775: epistatic circling B C57L/J (Eclb, Published QTL Chr 4)
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS174247: HP:0000539 Abnormality of refraction
|
|
GS185781: GO:0005594 collagen type IX
|
|
GS194227: GO:0030020 extracellular matrix structural constituent conferring tensile strength
|
|
GS201255: GO:0044421 extracellular region part
|
|
GS172253: HP:0001376 Limitation of joint mobility
|
|
GS204095: GO:0030182 neuron differentiation
|
|
GS175902: HP:0003468 Abnormality of the vertebrae
|
|
GS135364: B.burgdorferi-associated arthritis 23 (Bbaa23, Published QTL Chr 4)
|
|
GS176100: HP:0000925 Abnormality of the vertebral column
|
|
GS171848: HP:0000598 Abnormality of the ear
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS210236: GO:0000904 cell morphogenesis involved in differentiation
|
|
GS135612: circulating hormone level QTL 4 (Chlq4, Published QTL Chr 4)
|
|
GS136860: thermal pain response 1 (Tpnr1, Published QTL Chr 4)
|
|
GS172024: HP:0001369 Arthritis
|
|
GS136730: susceptibility to lung cancer 6 (Sluc6, Published QTL Chr 4)
|
|
GS171552: HP:0001382 Joint hypermobility
|
|
GS171392: HP:0003502 Mild short stature
|
|
GS136844: thymic lymphoma suppressor region 1 (Tlsr1, Published QTL Chr 4)
|
|
GS135477: bone response to mechanical loading 10 (Brml10, Published QTL Chr 4)
|
|
GS198230: GO:0005581 collagen
|
|
GS209568: GO:0048666 neuron development
|
|
GS172030: HP:0000365 Hearing impairment
|
|
GS172021: HP:0001367 Abnormal joint morphology
|
|
GS196806: GO:0032502 developmental process
|
|
GS208126: GO:0009605 response to external stimulus
|
|
GS210214: GO:0005576 extracellular region
|
|
GS171204: HP:0011314 Abnormality of long bone morphology
|
|
GS203594: GO:0043226 organelle
|
|
GS175293: HP:0005086 Knee osteoarthritis
|
|
GS195989: GO:0005593 FACIT collagen
|
|
GS207498: GO:0001501 skeletal system development
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS135741: dystrophic cardiac calcinosis 2 (Dyscalc2, Published QTL Chr 4)
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS202795: GO:0007409 axonogenesis
|
|
GS175530: HP:0000002 Abnormality of body height
|
|
GS176719: HP:0000541 Retinal detachment
|
|
GS171295: HP:0003508 Proportionate short stature
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS201060: GO:0042330 taxis
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS174091: HP:0004327 Abnormality of the vitreous humor
|
|
GS176223: HP:0003071 Flattened epiphyses
|
|
GS135551: CD4 virgin T cell subset 1 (Cd4vts1, Published QTL Chr 4)
|
|
GS194087: GO:0003674 molecular_function
|
|
GS171424: HP:0002814 Abnormality of the lower limb
|
|
GS210217: GO:0005578 proteinaceous extracellular matrix
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS136880: tooth shape 6 (Tshp6, Published QTL Chr 4)
|
|
GS171298: HP:0002829 Arthralgia
|
|
GS136757: startle response 2 (Start2, Published QTL Chr 4)
|
|
GS171631: HP:0008051 Abnormality of the retinal pigment epithelium
|
|
GS136540: psoriasis susceptibility 6 (Psrs6, Published QTL Chr 4)
|
|
GS208058: GO:0007411 axon guidance
|
|
GS135607: circulating hormone level QTL 16 (Chlq16, Published QTL Chr 4)
|
|
GS135394: body growth early QTL 3 (Bgeq3, Published QTL Chr 4)
|
|
GS171463: HP:0004279 Short palm
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS136580: red blood cell QTL 2 (Rbcq2, Published QTL Chr 4)
|
|
GS175557: HP:0002515 Waddling gait
|
|
GS136916: vertebral morphology and mechanical traits 4 (Vmmt4, Published QTL Chr 4)
|
|
GS176692: HP:0009815 Aplasia/Hypoplasia of the extremities
|
|
GS176559: HP:0000483 Astigmatism
|
|
GS205543: GO:0070013 intracellular organelle lumen
|
|
GS136100: lupus NZB x NZW 2 (Lbw2, Published QTL Chr 4)
|
|
GS129184: skin tumor susceptibility in FVB and PWK 1 (Skts-fp1 Published QTL Chr 4)
|
|
GS173787: HP:0002813 Abnormality of limb bone morphology
|
|
GS172848: HP:0000488 Retinopathy
|
|
GS129073: autoimmune glomerulonephritis in MRL 2 (Agnm2 Published QTL Chr 4)
|
|
GS195214: GO:0009987 cellular process
|
|
GS172110: HP:0002983 Micromelia
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS136936: vertebral trabecular bone trait 3 (Vtbt3, Published QTL Chr 4)
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS172699: HP:0002652 Skeletal dysplasia
|
|
GS175714: HP:0011389 Functional abnormality of the inner ear
|
|
GS136575: recognized antigen from MCA-induced tumor 1 (Ramt1, Published QTL Chr 4)
|
|
GS136422: pulmonary adenoma progression 1 (Papg1, Published QTL Chr 4)
|
|
GS200809: GO:0030030 cell projection organization
|
|
GS171512: HP:0007703 Abnormal retinal pigmentation
|
|
GS197025: GO:0044432 endoplasmic reticulum part
|
|
GS170971: HP:0000407 Sensorineural hearing impairment
|
|
GS135809: erosive arthritis susceptibility 2 (Erars2, Published QTL Chr 4)
|
|
GS135852: fecundity QTL 2 (Fecq2, Published QTL Chr 4)
|
|
GS172140: HP:0002857 Genu valgum
|
|
GS205691: GO:0022008 neurogenesis
|